Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 191

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

The Dual Role of Nrf2 in Nonalcoholic Fatty Liver Disease: Regulation of Antioxidant Defenses and Hepatic Lipid Metabolism

Open access
Chambel, Sílvia S., Santos-Gonçalves, Andreia, Duarte, Tiago L.·2015·BioMed Research International

Abstract

Nonalcoholic fatty liver disease (NAFLD) is a progressive liver disease with ever-growing incidence in the industrialized world. It starts with the simple accumulation of lipids in the hepatocyte and can progress to the more severe nonalcoholic steatohepatitis (NASH), which is associated with inflammation, fibrosis, and cirrhosis. There is increasing awareness that reactive oxygen species and electrophiles are implicated in the pathogenesis of NASH. Transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) is a positive regulator of the expression of a battery of genes involved in the protection against oxidative/electrophilic stress. In rodents, Nrf2 is also known to participate in hepatic fatty acid metabolism, as a negative regulator of genes that promote hepatosteatosis. We review relevant evidence in the literature that these two mechanisms may contribute to the protective role of Nrf2 in the development of hepatic steatosis and in the progression to steatohepatitis, particularly in young animals. We propose that age may be a key to explain contradictory findings in the literature. In summary, Nrf2 mediates the crosstalk between lipid metabolism and antioxidant defense mechanisms in experimental models of NAFLD, and the nutritional or pharmacological induction of Nrf2 represents a promising potential new strategy for its prevention and treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2015/597134

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 78

  1. 10.1007/978-1-4419-7107-4_10 · DOI
  2. 10.1016/j.freeradbiomed.2013.08.174 · DOI · Paper page
  3. 1960, Journal of Lipid Research, 1, 326, 10.1016/S0022-2275(20)39055-6 · doi:10.1016/s0022-2275(20)39055-6
  4. 2013, World Journal of Hepatology, 5, 550, 10.4254/wjh.v5.i10.550 · DOI · Paper page
  5. 10.1074/jbc.m109.026203 · DOI · Paper page
  6. 10.1016/j.jhep.2010.06.044 · DOI · Paper page
  7. 10.1016/j.plipres.2012.10.004 · DOI · Paper page
  8. 10.1001/jama.287.3.356 · DOI · Paper page
  9. 10.1089/met.2008.0070 · DOI · Paper page
  10. 10.1111/j.1464-5491.2006.01858.x · DOI · Paper page
  11. 10.1016/j.bpg.2014.07.008 · DOI · Paper page
  12. 10.1002/hep.510270601 · DOI · Paper page
  13. 10.1155/2013/327167 · DOI · Paper page
  14. 10.1586/egh.11.4 · DOI · Paper page
  15. 10.1111/liv.12523 · DOI
  16. 10.1016/j.taap.2010.03.016 · DOI · Paper page
  17. 10.1093/carcin/bgp100 · DOI · Paper page
  18. 10.1016/j.jprot.2010.03.018 · DOI · Paper page
  19. 10.1124/jpet.107.135822 · DOI · Paper page
  20. 10.1111/j.1440-1746.2012.07180.x · DOI
  21. 10.1016/j.taap.2012.09.014 · DOI
  22. 10.1016/j.ejphar.2009.08.022 · DOI · Paper page
  23. 10.1152/ajpgi.00322.2010 · DOI · Paper page
  24. 10.1074/jbc.m110.176545 · DOI
  25. 10.1016/j.freeradbiomed.2011.11.012 · DOI
  26. 10.1007/s00535-012-0552-9 · DOI
  27. 10.1124/mol.112.084269 · DOI
  28. 10.1016/j.freeradbiomed.2014.03.025 · DOI · Paper page
  29. 10.1021/tx050217c · DOI · Paper page
  30. 10.1073/pnas.94.10.5361 · DOI · Paper page
  31. 10.1146/annurev.pharmtox.43.100901.140229 · DOI · Paper page
  32. 10.1074/jbc.m211558200 · DOI · Paper page
  33. 10.1016/j.freeradbiomed.2011.11.038 · DOI · Paper page
  34. 10.1016/j.biocel.2005.09.018 · DOI · Paper page
  35. 10.1074/jbc.m412081200 · DOI · Paper page
  36. 10.1016/j.tibs.2014.02.002 · DOI · Paper page
  37. 10.1016/j.mrrev.2007.11.006 · DOI · Paper page
  38. 10.1016/j.jhep.2010.11.005 · DOI · Paper page
  39. 10.1038/ncb2021 · DOI · Paper page
  40. 10.1038/embor.2011.246 · DOI
  41. 10.1242/bio.20134853 · DOI · Paper page
  42. 10.1042/BJ20130863 · DOI · Paper page
  43. 10.1080/01926230701311344 · DOI · Paper page
  44. 10.1016/j.taap.2010.01.013 · DOI · Paper page
  45. 10.1155/2013/305861 · DOI
  46. 10.1016/j.taap.2011.07.019 · DOI
  47. 10.1038/labinvest.2008.75 · DOI · Paper page
  48. 10.1016/j.jhep.2013.09.004 · DOI
  49. 1991, The Biochemical Journal, 277, 723, 10.1042/bj2770723 · DOI
  50. 10.1002/hep.22473 · DOI
  51. 10.1007/s11745-010-3492-2 · DOI
  52. 10.1038/sj.emboj.7601950 · DOI · Paper page
  53. 10.2119/molmed.2013.00027 · DOI
  54. 10.1111/acel.12128 · DOI · Paper page
  55. 10.1073/pnas.0400282101 · DOI · Paper page
  56. 10.1007/s10522-006-9033-y · DOI · Paper page
  57. 10.1016/S0891-5849(03)00073-X · DOI
  58. 10.1161/circresaha.108.188771 · DOI · Paper page
  59. 10.1007/s11892-013-0372-1 · DOI
  60. 10.1124/dmd.110.035006 · DOI · Paper page
  61. 10.1152/ajpgi.00296.2009 · DOI · Paper page
  62. 10.1016/j.freeradbiomed.2009.11.007 · DOI · Paper page
  63. 10.1186/1476-511x-12-165 · DOI
  64. 10.1007/s00535-012-0659-z · DOI
  65. 2004, Molecular Cancer Therapeutics, 3, 885, 10.1158/1535-7163.885.3.7 · DOI · Paper page
  66. 10.1021/jm980424s · DOI · Paper page
  67. 10.1073/pnas.051618798 · DOI · Paper page
  68. 10.1158/0008-5472.CAN-04-4539 · DOI · Paper page
  69. 10.1158/0008-5472.CAN-04-1906 · DOI · Paper page
  70. 10.1523/jneurosci.1683-07.2007 · DOI · Paper page
  71. 10.1158/0008-5472.CAN-05-3823 · DOI · Paper page
  72. 2012, Clinical Pharmacology & Therapeutics, 92, 340, 10.1038/clpt.2012.110 · DOI · Paper page
  73. 10.1016/j.freeradbiomed.2005.08.043 · DOI · Paper page
  74. 10.1016/S0140-6736(08)61619-0 · DOI · Paper page
  75. 10.1158/1535-7163.MCT-06-0516 · DOI · Paper page
  76. 10.5483/BMBRep.2005.38.2.167 · DOI
  77. 10.1016/j.freeradbiomed.2011.09.017 · DOI
  78. 10.3390/ijms141121240 · DOI · Paper page

Cited by

See all 191

Metadata

Authors
Chambel, S. S., Santos-Gonçalves, A., & Duarte, T. L.
Venue
BioMed Research International
Publisher
Wiley
Published
2015
Volume
2015
Pages
1-10
ISSN
  • 1110-7243 (ISSN-L)
  • 2314-6133
  • 2314-6141
OpenAlex
W1554837601
Cited by
191
References
9
FWCI
3.60
Type
journal article
Language
en
Open access
hybrid
Funders
Fundação para a Ciência e a Tecnologia (FCOMP-01-0124-FEDER-028447)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Dual Role of Nrf2 in Nonalcoholic Fatty Liver Disease: Regulation of Antioxidant Defenses and Hepatic Lipid Metabolism. https://app.cochat.ai/papers/10.1155/2015/597134
The paper
Chambel, S. S., Santos-Gonçalves, A., & Duarte, T. L. (2015). The Dual Role of Nrf2 in Nonalcoholic Fatty Liver Disease: Regulation of Antioxidant Defenses and Hepatic Lipid Metabolism. BioMed Research International. https://doi.org/10.1155/2015/597134

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.